Target intelligence / Profile preview

N-acetyl-p-benzoquinone imine (NAPQI) (NAPQI)

Target
NAPQI
Molecular classification
Other (toxic reactive metabolite), Quinone imine
01

Overview

N-acetyl-p-benzoquinone imine (NAPQI) is the principal reactive metabolite formed during acetaminophen metabolism. Generated by cytochrome P450 oxidation, NAPQI is highly electrophilic and binds covalently to cellular thiols, especially glutathione. At therapeutic doses, NAPQI is rapidly detoxified by conjugation with glutathione, but in overdoses or compromised detoxification, buildup of NAPQI causes extensive hepatic and cellular protein damage, leading to hepatotoxicity. NAPQI and related reactive metabolites also interact with hepatic enzymes such as thioredoxin reductase, further contributing to oxidative stress and liver injury. The metabolites can sensitize and activate TRPV1 channels, potentially influencing analgesic and cytotoxic effects. Drug interventions focus on preventing or reversing NAPQI toxicity by replenishing glutathione reserves or modulating its formation.

Other names
Reactive acetaminophen metabolitesNAPQIp-benzoquinone imineAPAP reactive metaboliteacetaminophen electrophilic intermediate
02

Mechanism of action

Toxic metabolites covalently bind to and damage hepatic proteins and enzymes (e.g., glutathione, thioredoxin reductase)\nCause cell death by depleting cellular antioxidants\nSensitize and activate TRPV1 channels

03

Biological functions

Covalent binding to cellular macromoleculesProtein and enzyme inhibition (e.g., thioredoxin reductase)Induction of oxidative stressToxin formation leading to cell death and liver injury
04

Disease associations

Liver toxicity/hepatotoxicityCytotoxicity in overdoseKidney injury (in animal models)
05

Safety considerations

Hepatotoxicity in overdose or impaired detoxificationDepletion of glutathione, leading to oxidative stress and cell deathEnzyme inhibition (e.g., thioredoxin reductase)Not directly druggable, but targeted by antidotes (N-acetylcysteine, methionine)
06

Interacting drugs

N-acetylcysteine (antidote)

3 more in the full profile.

07

Biomarkers

Urinary acetaminophen-cysteine (APAP-cys) conjugateBlood glutathione levelsSNPs in UGT1A1-3’UTR region (e.g., rs8330) linked to acetaminophen glucuronidation

Beyond the preview

Go deeper on N-acetyl-p-benzoquinone imine (NAPQI) (NAPQI).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on N-acetyl-p-benzoquinone imine (NAPQI) (NAPQI).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call